Explore more publications!
Mississippi Healthcare Reporter
Submit Press Release

Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 13, 2025

ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates
November 13, 2025

ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates

Indeterminate GlobeNewswire
Fennec Pharmaceuticals Announces Proposed Offering of Common Shares
November 13, 2025

Fennec Pharmaceuticals Announces Proposed Offering of Common Shares

Indeterminate GlobeNewswire
Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 13, 2025

Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
November 13, 2025

Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update

Indeterminate GlobeNewswire
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
November 13, 2025

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025

Indeterminate GlobeNewswire
Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis
November 13, 2025

Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis

Indeterminate GlobeNewswire
BioSyent Schedules Q3 and YTD 2025 Earnings Release for November 20, 2025
November 13, 2025

BioSyent Schedules Q3 and YTD 2025 Earnings Release for November 20, 2025

Indeterminate GlobeNewswire
BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
November 13, 2025

BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Indeterminate GlobeNewswire
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
November 13, 2025

Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
ORIC® Pharmaceuticals Announces Completion of Dose Exploration Portion of ORIC-944 Phase 1b Clinical Trial and Continues to Demonstrate Potential Best-in-Class Efficacy and Safety
November 13, 2025

ORIC® Pharmaceuticals Announces Completion of Dose Exploration Portion of ORIC-944 Phase 1b Clinical Trial and Continues to Demonstrate Potential Best-in-Class Efficacy and Safety

Indeterminate GlobeNewswire
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
November 13, 2025

Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis

Indeterminate GlobeNewswire
CapsoVision Reports Third Quarter 2025 Financial Results
November 13, 2025

CapsoVision Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
November 13, 2025

Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update

Indeterminate GlobeNewswire
PacBio to Present at Upcoming Investor Conferences
November 13, 2025

PacBio to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025

Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
November 13, 2025

STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights
November 13, 2025

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

Indeterminate GlobeNewswire
RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update
November 13, 2025

RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update

Indeterminate GlobeNewswire
Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates
November 13, 2025

Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates

Indeterminate GlobeNewswire
Profound Medical Reports Strong Third Quarter 2025 Financial Results
November 13, 2025

Profound Medical Reports Strong Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions